TipRanks
Bioethics (BOTH)
OTHER OTC:BOTH
US Market
BOTH
Bioethics
RESEARCH TOOLSreports

Bioethics (BOTH) Income Statement

12 Followers

Bioethics Income Statement

Last quarter (Q4 2024), Bioethics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Bioethics's net income was $-48.29K. See Bioethics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -226.00$ -286.00
Operating Expenses
$ 122.82K$ 50.44K$ 47.30K$ 59.37K$ 75.14K
Depreciation and Amortization
$ 122.82K$ 50.44K$ 226.00$ 226.00$ 286.00
EBITDA
$ -122.82K$ 0.00$ -47.08K$ -59.14K$ -74.86K
Operating Income
$ -122.82K$ -50.44K$ -47.30K$ -59.37K$ -75.14K
Other Income/Expenses
$ -54.14K$ -46.71K$ -45.90K$ -47.82K$ -44.05K
Pretax Income
$ -176.96K$ -97.15K$ -93.20K$ -107.18K$ -119.19K
Net Income
$ -176.96K$ -97.15K$ -93.20K$ -107.18K$ -119.19K
Per Share Metrics
Basic EPS
$ -0.12$ -0.09$ -0.08$ -0.09$ -0.10
Diluted EPS
$ -0.12$ -0.09$ -0.08$ -0.09$ -0.10
Weighted Average Shares Outstanding
 1.49M 1.14M 1.14M 1.14M 1.14M
Weighted Average Shares Outstanding (Diluted)
 1.49M 1.14M 1.14M 1.14M 1.14M
Currency in USD

Bioethics Earnings and Revenue History